/
Planning For Scarce Pediatric Pharmaceutical Resources Planning For Scarce Pediatric Pharmaceutical Resources

Planning For Scarce Pediatric Pharmaceutical Resources - PowerPoint Presentation

tatyana-admore
tatyana-admore . @tatyana-admore
Follow
387 views
Uploaded On 2017-12-20

Planning For Scarce Pediatric Pharmaceutical Resources - PPT Presentation

Arizona Pediatric Emergency Preparedness Sue Moravec PharmD Chief Pharmacy OfficerAVP Pharmacy Services May 23 rd 2017 Disclosure Nothing to disclose Except Planning Pediatric Drug Shortage ID: 616970

shortage drug shortages emergency drug shortage emergency shortages pediatric drugs care overview fda pharmacy countermeasures vials cdc prepare market

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Planning For Scarce Pediatric Pharmaceut..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Planning For Scarce Pediatric Pharmaceutical Resources

Arizona

Pediatric Emergency

Preparedness

Sue Moravec, PharmD

Chief Pharmacy Officer/AVP

Pharmacy Services

May 23

rd

, 2017Slide2

DisclosureNothing to disclose

Except….Slide3

Planning Pediatric Drug ShortageSlide4

Drug Shortage Overview

Right

NOW!

Sodium Bicarbonate, D50

Electrolytes

K

Phos

, Na

Acet

,

Calcium Cl, Cal GluconateAll Emergency SyringesEpi, Norepi, AtropineRocuronium, VecuroniumLidocaineFentanyl, Morphine

Sample email from FridaySlide5

Drug Shortage Overview

Epi,Atro,Bicar,Dex,Cal,Lido

Lido,Fent,Roc,Vec,AtrSlide6

Drug Shortage Overview

Drug shortage is a supply issue that affects how the pharmacy prepares or dispenses a drug product or influences patient care when prescribers must use an alternative agent.

ASHPSlide7

Drug Shortage Overview

Drug shortages are of

particular concerning emergency care settings

where providers must rapidly treat ill and injured patients.

For most medications, substitutes exist, but may

not be as effective

, and may have

more side effects

, and providers are

inexperienced

in using them, which could lead to increase errors such as dosing or interactions Slide8

Drug Shortage Overview

Utah Emergency MDs 2016

One-third of all drug shortages are within the scope of emergency medicine

(1789)

Shortages of drugs with no substitute grew 125%

From 2008-2014, emergency medicine

drug shortages

rose by 435%

(23 to 123 drugs)

Life-saving or high acuity shortage drugs increased 393

% * (2017 – more)Slide9

Drug Shortage Overview

True reasons around shortages remains unknown.

Multiple disease states

Infectious disease, analgesia, toxicology, critical care

Around 40% of drug shortages affect emergency care

Health Human Services Emergency Care Coordination

6. Median shortage time is about 9 monthsSlide10

Causes

#1 reason Manufacturing difficulties

Hospira syringes

AGAIN! glass

Stricter FDA –due to black market

OLD buildings

Alternatives

– Supply/Demand

Sodium Bicarbonate -> Sodium

Acetate

Normal Saline -> Conc. NACL vials/Sterile Water BagsRaw materials shortageFentanyl*Recalls (*sometime your first hint to a shortage)Business/economic pressures (generics)“One assembly line”Slide11

Consequences

Finger pointing – Manufacturers -> Distribution -> rising prices

Incomplete disclosure of drug

shortages

2017 – New transparency regulation

Difficulties in determining inventories in real-time

Buyers – watching internet

Difficulties associating shortages with clinical outcomes in a population

Clinical

Adjustments

Sub optimal therapiesPoor outcomesSlide12

Consequences

Emergency

/ Critical Care Protocols

(all change)

Shortage of anesthesia drugs

/ PAR levels

Lots of errors, miss-dosing, look

alikes

, delay in care

Angry MDs / Clinicians / Administration

Psychological consequenceStaff -> patientsOncology shortagesCOSTS!!!! Major financial burdenIV DiphenhydramineIV Compazine Slide13

Pediatric

Pharmacokinetics

They are NOT ‘little

adults’ (dose by kg)

Extremely vulnerable – ABC - *A - respiratory

ADME - pharmacokinetics

Absorption

Shorter GI, Skin, Respiratory, IV

Distribution

Lipid drugs – rapid absorption, Water based-rapid eliminationMetabolismIn general ‘faster’ –antibioticsExcretionMore age related / renal function / hydrationSlide14

Pediatric

Pharmacokinetics

Even the FDA says so ..

Some doses are higher

Some are lower

Alternatives / substitutions – need to be evaluated --- especially different routes of adminSlide15

Countermeasures

FDA

allowing

a lot

foreign products

NS/IV from Mexico/Spain (Baxter

)

*no bar code, look different, tubing

Homework… check vials.. India

Communication (be proactive)SBAR –weekly, now 2x Action Plans Alternative sizes, vials, strengths, doses System to notify – act quickly Frequent updates help reassureSlide16

CommunicationSlide17

CommunicationSlide18

Countermeasures

Collaborations within / outside

Regulations - Track

/

trace – Banner/

Abrazo

/Dignity

“Emergency Protocol”

Allowing for extending outdates – 3-6 month

Allowing Multi-dose vials or SDV more than once

PropofolGray market (black market)Compounding CentersRaw materials / powdersRegulations – Do your homework!Slide19

Black Market

Google location!

4.5 / 5 Yelp

Groupons

Some don’t have street view

Check FDA / State Board Slide20

Countermeasures

Proactively update most used protocols

D50 – 10% Dextrose, Oral, Gels, Tablets (PR)

Adjust thresholds – Remove give ½ amp

Disaster

drills/exercises should include

practice

in estimation of dosages for pediatric patients.

Many “visual” signs –

Peds

chartsNeed updated with alternativesSlide21

Countermeasures

Collaboration with nursing, physicians, EMS, pharmacy - (different routes, doses)

Preferred Pediatric Emergency – usually have good committees – increase frequency

Compounding “own” syringes *risky

Restrict drugs to high risk populations

Prepare long term plan

Access CDC stockpile Slide22

Countermeasures

Definitely see frequent product changes

Prepare to have different vials / strengths

Prepare to have different colored syringes - IMS

Prepare to have lower PAR levels

Pediatrics

Key is parents – communication

Awareness

Education – professional,

KNOW your pharmacy teamSlide23

Planning Pediatric Drug ShortageSlide24

Resources

ASHP Drug Shortages Website https://www.ashp.org/shortages

FDA Drug Shortage Website http://www.fda.gov/Drugs/DrugSafety/DrugShortages/default.htm

CDC Vaccine Shortage and Delays Website http://www.cdc.gov/vaccines/vac-gen/shortages/

Product Manufacturers

CDC / Emergency Prep

Moving TargetSlide25

Questions

Thank you